· Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: a marker of advanced disease and electrical myocardial instability.
Todiere G, Pisciella L, Barison A, Del Franco A, Zachara E, Piaggi P, Re F, Pingitore A, Emdin M, Lombardi M, Aquaro GD;
· A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD).
Constantinos O’Mahony, Fatima Jichi, Menelaos Pavlou, Lorenzo Monserrat,
Aristides Anastasakis, Claudio Rapezzi, Elena Biagini, Juan Ramon Gimeno,
Giuseppe Limongelli, WilliamJ. McKenna, Rumana Z.Omar, and Perry M. Elliott,
for the Hypertrophic Cardiomyopathy Outcomes Investigators;
· High signal intensity on T2-weighted cardiac magnetic resonance imaging correlates with the ventricular tachyarrhythmia in hypertrophic cardiomyopathy
Yasuki Hen • Nobuo Iguchi • Haruhiko Machida •
Kaori Takada • Yuko Utanohara • Tetsuya Sumiyoshi;
· Cardiovascular magnetic resonance signs of ischemia
in hypertrophic cardiomyopathy
Paola Melacini, Francesco Corbetti, Chiara Calore, Valentina Pescatore,
Gessica Smaniotto, Andrea Pavei, Fabiana Bobbo, Luisa Cacciavillani, Sabino Iliceto;
Myocarditis in hypertrophic cardiomyopathy patients presenting acute clinical deterioration;
Andrea Frustaci, Romina Verardo, Marina Caldarulo, Maria Cristina Acconcia, Matteo A. Russo, and Cristina Chimenti;